Drug Updates

High Cost, No Benefit

Aryeh M. Abeles, MD | July 12, 2011

Why are so many brand-name drugs approved after generic versions become available?

Information on New Approvals and Medication Safety

Information on New Approvals and Medication Safety

Dimitrios T. Boumpas, MD; George Bertsias, MD | April 13, 2011

It’s time for a new strategy

Sue Pondrom | April 13, 2011

Safety events vary among different opioids

Information on New Approvals and Medication Safety

Vanessa Caceres | March 18, 2011

Panel considered new drugs and tools in the 2010 update

Kathy Holliman | March 18, 2011

Updated recommendations advocate doing more to determine fracture risk and the need for preventive therapy

Mary Desmond Pinkowish | March 18, 2011

Recent meta-analysis points to MI risks, but many questions remain

By Mary Desmond Pinkowish | March 18, 2011

NIH conference brings together experts to discuss pain treatment